- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 160.18M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $975M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $944.4M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $146.8M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $159.6M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $16M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $14.8M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $988.1M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.01B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $684.5M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $660M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.9B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.85B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $669.8M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $574.1M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.02B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.99B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 159.8M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $59.9M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $79.1M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $50.6M |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.8M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $39.9M |
| Revenue | Q1 2025 · Mar 31, 2024 | $581.5M |